MIR4730: A Potential Drug Target and Biomarker (G100616359)

MIR4730: A Potential Drug Target and Biomarker

MIR4730 is a protein that is expressed in various tissues of the body, including the brain, heart, and kidneys. It is a member of the MIR family of RNA-binding proteins, which are known for their ability to interact with RNA molecules. One of the unique features of MIR4730 is its ability to form a stable complex with double-stranded RNA, which are often found in the brain.

The MIR4730 protein has been shown to play a role in various physiological processes in the body, including cell signaling, DNA replication, and gene expression. It is also expressed in various diseases, including cancer, neurodegenerative diseases, and systemic diseases.

Due to its unique structure and function, MIR4730 has been identified as a potential drug target. By targeting MIR4730, researchers hope to develop new treatments for a variety of diseases.

One of the main advantages of targeting MIR4730 is its potential to affect a wide range of cellular processes. MIR4730 has been shown to interact with a variety of RNA molecules, including microRNAs, which are short snippets of RNA that are produced by the DNA machine. These microRNAs play a critical role in regulating gene expression, and MIR4730 has been shown to be involved in the regulation of microRNA levels.

In addition to its role in cellular signaling, MIR4730 is also involved in the regulation of gene expression. It has been shown to interact with the transcription factor p53, which is a protein that plays a critical role in regulating gene expression. This interaction suggests that MIR4730 may be involved in the regulation of gene expression, which could be a potential target for new drugs.

Another potential advantage of targeting MIR4730 is its potential to affect the development of cancer. MIR4730 has been shown to be expressed in various types of cancer, including breast, ovarian, and prostate cancer. Additionally, MIR4730 has been shown to play a role in the regulation of cell cycle progression, which is a critical step in the development of cancer.

Targeting MIR4730 may also have potential benefits for neurodegenerative diseases. MIR4730 has been shown to be involved in the regulation of neurotransmitter release from neurons, which is important for maintaining proper brain function. Additionally, MIR4730 has been shown to interact with the protein brain-derived neurotrophic factor (BDNF), which is a protein that is involved in the support of brain function. This interaction suggests that MIR4730 may be involved in the regulation of brain function, which could be a potential target for new drugs to treat neurodegenerative diseases.

In conclusion, MIR4730 is a protein that has been shown to play a role in a wide range of physiological processes in the body. Its unique structure and function make it an attractive target for new drugs. The potential benefits of targeting MIR4730 include its potential to affect a wide range of cellular processes, including cell signaling, DNA replication, and gene expression, as well as its potential to affect the development of cancer and neurodegenerative diseases. Further research is needed to fully understand the mechanisms of MIR4730 and its potential as a drug target.

Protein Name: MicroRNA 4730

The "MIR4730 Target / Biomarker Review Report" is a customizable review of hundreds up to thousends of related scientific research literature by AI technology, covering specific information about MIR4730 comprehensively, including but not limited to:
•   general information;
•   protein structure and compound binding;
•   protein biological mechanisms;
•   its importance;
•   the target screening and validation;
•   expression level;
•   disease relevance;
•   drug resistance;
•   related combination drugs;
•   pharmacochemistry experiments;
•   related patent analysis;
•   advantages and risks of development, etc.
The report is helpful for project application, drug molecule design, research progress updates, publication of research papers, patent applications, etc. If you are interested to get a full version of this report, please feel free to contact us at BD@silexon.ai

More Common Targets

MIR4731 | MIR4732 | MIR4733 | MIR4734 | MIR4735 | MIR4736 | MIR4737 | MIR4738 | MIR4739 | MIR4740 | MIR4741 | MIR4742 | MIR4745 | MIR4746 | MIR4747 | MIR4749 | MIR4750 | MIR4751 | MIR4752 | MIR4753 | MIR4754 | MIR4755 | MIR4756 | MIR4757 | MIR4758 | MIR4759 | MIR4760 | MIR4761 | MIR4762 | MIR4763 | MIR4764 | MIR4765 | MIR4766 | MIR4767 | MIR4768 | MIR4769 | MIR4770 | MIR4771-1 | MIR4771-2 | MIR4772 | MIR4773-1 | MIR4773-2 | MIR4774 | MIR4775 | MIR4776-1 | MIR4776-2 | MIR4777 | MIR4778 | MIR4779 | MIR4780 | MIR4781 | MIR4782 | MIR4783 | MIR4784 | MIR4785 | MIR4786 | MIR4787 | MIR4789 | MIR4790 | MIR4791 | MIR4793 | MIR4794 | MIR4795 | MIR4796 | MIR4797 | MIR4798 | MIR4799 | MIR4800 | MIR4802 | MIR4803 | MIR4804 | MIR483 | MIR484 | MIR485 | MIR486-1 | MIR486-2 | MIR487A | MIR487B | MIR488 | MIR489 | MIR490 | MIR491 | MIR492 | MIR493 | MIR494 | MIR495 | MIR496 | MIR497 | MIR497HG | MIR498 | MIR4999 | MIR499A | MIR499B | MIR5000 | MIR5001 | MIR5002 | MIR5003 | MIR5004 | MIR5006 | MIR5007